Overnutrition causes insulin resistance and metabolic disorder through increased sympathetic nervous system activity
Cell Metabolism · 2025
DOI: 10.1016/j.cmet.2024.09.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Metabolism, 2025. Verfasst von Kenichi Sakamoto und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism & Nutrition, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA; Depart…. Hauptthemen laut MEDLINE: Insulin Resistance, Overnutrition, Sympathetic Nervous System. Die Arbeit wurde bisher 110-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIAAA NIH HHS.
Abstract (Originalsprache)
The mechanisms underlying obesity-induced insulin resistance remain incompletely understood, as impaired cellular insulin signaling, traditionally considered the primary driver of insulin resistance, does not always accompany impaired insulin action. Overnutrition rapidly increases plasma norepinephrine (NE), suggesting overactivation of the sympathetic nervous system (SNS). However, the role of the SNS in obesity is controversial, as both increased and decreased SNS activity (SNA) have been reported. Here, we show that reducing catecholamine (CA) release from the SNS protects against overnutrition-induced insulin resistance as well as hyperglucagonemia, adipose tissue dysfunction, and fatty liver disease, as we demonstrate utilizing a mouse model of inducible and peripherally restricted deletion of tyrosine hydroxylase (th; THΔper). A key mechanism through which heightened SNA induces insulin resistance is by triggering adipose tissue lipolysis. Increased SNA emerges as a critical driver in the pathogenesis of overnutrition-induced insulin resistance and metabolic disease independent of cellular insulin signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Metabolism & Nutrition, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA; Department of Medicine and Diabetes, Obesity, and Metabolism Institute, Icah…
- Department of Medicine and Diabetes, Obesity, and Metabolism Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Division of Endocrinology, Metabolism & Nutrition, Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
- Department of Neuroscience and Pharmacology, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
- Department of Medicine & Neuroscience, Albert Einstein College of Medicine, New York, NY, USA.
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIAAA NIH HHS
- BLRD VA
- NICHD NIH HHS
- NIA NIH HHS
- US Department of Defense
- US Department of Veterans Affairs
Zitieren
APA
Sakamoto, K., Butera, M. A., Zhou, C., Maurizi, G., Chen, B., Ling, L., Shawkat, A., Patlolla, L., Thakker, K., Calle, V., Morgan, D. A., Rahmouni, K., Schwartz, G. J., Tahiri, A., & Buettner, C. (2025). Overnutrition causes insulin resistance and metabolic disorder through increased sympathetic nervous system activity. Cell Metabolism. https://doi.org/10.1016/j.cmet.2024.09.012
Vancouver
Sakamoto K, Butera MA, Zhou C, Maurizi G, Chen B, Ling L, et al. Overnutrition causes insulin resistance and metabolic disorder through increased sympathetic nervous system activity. Cell Metabolism. 2025. doi:10.1016/j.cmet.2024.09.012
BibTeX
@article{Sakamoto2025,
author = {Sakamoto, Kenichi and Butera, Mary A and Zhou, Chunxue and Maurizi, Giulia and Chen, Bandy and Ling, Li and Shawkat, Adham and Patlolla, Likhitha and Thakker, Kavira and Calle, Victor and Morgan, Donald A and Rahmouni, Kamal and Schwartz, Gary J and Tahiri, Azeddine and Buettner, Christoph},
title = {Overnutrition causes insulin resistance and metabolic disorder through increased sympathetic nervous system activity},
journal = {Cell Metabolism},
year = {2025},
doi = {10.1016/j.cmet.2024.09.012}
}
EUVIMED